Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Opinions Peter Hodson
Draxis Health IncDAX.TOBUY ON WEAKNESSMar 02, 2004
Likes what the company is doing. Starting to develop their US relationships. Last quarterly results were excellent. On his watch list.
$6.10
Stock price when the opinion was issued
biotechnologypharmaceutical
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
You might be interested:
TOP PICK
Good technical pattern. Has been in a congestion area for quite awhile, went through a bit of a correction and has just broke out.
Ron MeiselsOwned
biotechnologypharmaceutical
TOP PICK
Forecasting 35/40% on manufacturing growth. Earnings are growing substantially from three cents to eight cents. Sales growth of 27%.
Robert McWhirterOwned
biotechnologypharmaceutical
TOP PICK
Earnings revisions is up 13%. Year-over-year sales are up 29%. Earnings growth is up 107%.
Robert McWhirterOwned
biotechnologypharmaceutical
